Detalhe da pesquisa
1.
Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
Ann Hematol
; 98(1): 47-53, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132072
2.
Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.
Br J Haematol
; 183(4): 648-660, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334577
3.
Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.
Ann Hematol
; 101(8): 1859-1860, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293609
4.
Newborn Screening for Sickle Cell Disease and Other Hemoglobinopathies: A Short Review on Classical Laboratory Methods-Isoelectric Focusing, HPLC, and Capillary Electrophoresis.
Int J Neonatal Screen
; 4(4): 39, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33072959
5.
Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants.
Biomed Res Int
; 2014: 695828, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25147811
6.
Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.
Eur J Hum Genet
; 22(8): 1051-3, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24398797